Andrew M. Dahl - 13 Nov 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
SVP, Corporate Controller
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
13 Nov 2025
Net transactions value
$0
Form type
4
Filing time
13 Nov 2025, 19:52:12 UTC
Previous filing
15 Sep 2025
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dahl Andrew M. SVP, Corporate Controller ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 13 Nov 2025 0002022347

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Award $0 +1,160 +14% $0.000000 9,183 13 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on November 13, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.